Investing in China's Pharmaceutical Industry is the second edition of a paper published by PricewaterhouseCoopers looking into the current pharmaceutical market conditions in China. The report covers various subjects that are considered to be of concern to the pharmaceutical industry and/or investors in the pharmaceutical (pharma) industry in China. Building on the foundation set in the first report,...
IRELAND’S pharmaceutical industry needs to change and adapt if it wants to avoid being left behind, a conference in Cork involving key players in the field has been told.
Ireland’s drug regulator has been accused of being too close to the pharmaceutical industry. An academic report has concluded that more than one-in-four senior personnel at the Irish Medicines Board (IMB) had “potential conflicts of interest”. The Sunday Times
Shutting off the miracle-drug spigot Pelosi's bill may cost pharmaceutical companies $150 billion over a decade -- nearly double the amount they conceded when they cut a White House-approved deal with Sen. Max Baucus this summer. The Pelosi bill is a prescription for fewer new life-saving drugs. By stifling innovation, it would hurt not only industry, but also all of us who'd benefit from new-drug...
Recognizing its significant contributions to increasing U.S. exports, Medtronic, Inc., (NYSE: MDT) received President Barack Obama's "E" Award on Thursday, Nov. 5. The ceremony, held in the U.S. Department of Commerce, was part of the District Export Council Conference in Washington D.C. The award recognized Medtronic and other individuals and companies for their efforts in promoting and...
After completely misstating the effect of this bill on veterans, and then screaming like a madman on the floor of the United States House of Representatives, Buyer went back to his office and counted the hundreds of thousands of dollars he, his family, and his campaign staff have indirectly (and in some cases directly) received from the pharmaceutical industry through his fake charity .
Connecting the Dots in the New World Order (Free subscription) | yesterday
It’s not your fault, ladies (and certainly not your partner’s), that you don’t orgasm every time you have intercourse, or that you lack the libido of a 17-year-old boy. You have a disease: female sexual dysfunction (FSD), and the pharmaceutical industry wants to help. You are among the "43 percent of American women [who] experience some degree of impaired sexual function,"...
Concerned over the recent takeover of some firms by MNCs, the domestic pharmaceutical industry has asked the government to protect and promote it by making funds available for research and development.
News outlets focus on alleged fraud in the drug and insurance industries. "A $112 million settlement involving alleged drug kickbacks that the Justice Dept. announced with the nation's largest nursing home pharmacy and a generic drug manufacturer on Nov. 3 is part of a wide-ranging investigation of suspected Medicaid fraud by the pharmaceutical industry,"
About Macleods Pharmaceuticals Ltd : Macleods is a leader in various therapeutic segments in the Indian pharmaceutical Industry. Macleods is amongst the fastest growing pharmaceutical companies in India, jumping 26 ranks in 5 years. Currently Macleods is ranked 22nd in the Indian pharmaceutical industry. At Macleods we believe in brand building, the result is attaining No.1 [...]
Helix BioPharma Corp. (TSX, FSE: "HBP" / OTCQX: HXBPF) announced that its Phase II trial of Topical Interferon Alpha-2b for the treatment of ano-genital warts (AGW) has completed patient enrollment, with the required 120th patient randomized to enter the trial. The double-blind and placebo-controlled Phase II trial is underway at multiple centers in Germany and Sweden.
Amgen (Nasdaq: AMGN) announced that the Phase 3 PRIME "203" trial evaluating Vectibix® (panitumumab) administered in combination with FOLFOX (an oxaliplatin-based chemotherapy) as a first-line treatment of metastatic colorectal cancer (mCRC) failed to meet a secondary endpoint of overall survival.
I saw something rather disturbing this evening: an ad talking about erectile dysfunction. Hardly an uncommon sight in itself - except this one was on a Canadian station. I believe it was CTV NewsChannel. Unlike those endless, annoying American drug ads, this one didn't mention any specific drug - just informed the viewer that (apparently) 40% of men over 40 suffer from E.D. and referred them to a website:...
Shane Ellison has a masters degree in organic chemistry and is a two-time recipient of the prestigious Howard Hughes Medical Institute Research Grant for his studies in biochemistry and physiology. Here Shane exposes the inner workings of the psycho/pharmaceutical industry, the manufacture and marketing of psychiatric drugs and the fact that the psycho/pharma industry is well aware their drugs do...
The Middle East and Africa pharmaceutical industry is entering a new era, with the development of infrastructure system and rapidly changing regulations. The industry is blessed with several advantages like high prevalence of diseases, huge population base and many more, reflecting bight prospects of growth in coming years. With these supportive factors, the pharmaceutical industry in the MEA region
Be Part of the Great Movement of Preventing Stroke and Heart Diseases: "From bench to bedside and community" TAIPEI, Taiwan, Oct. 30 /PRNewswire-Asia/ -- According to the theme of WHC 2009 in Beijing: from bench to bedside and community, Microlife is promoting a total solution for hypertension management. This solution entails a series of innovative professional blood pressure measurement devices designed...
Speciality medicines (specialty in the US) have become one of the main drivers of pharmaceutical industry growth. High tech, ‘high touch’ products with premium prices targeted at chronic, complex diseases, often requiring special storage and handling, with help with dosage administration, close monitoring and ongoing support for the patient needed. Manufacturers of speciality medicines seek a competitive...
Videos
